| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |